Breadcrumb

Proof of concept study on a potential gene therapy will be supported by the Yaya Foundation
RI-MUHC ANNUAL REPORT 2021CHARTING THE COURSE TO A POST-PANDEMIC WORLD“We need a global vision to tackle a global pandemic,” says...
NEXT READ Focus on our trainees Your support PREVIOUS READ ...
NEXT READ YEAR IN REVIEW: Translational Research in Respiratory Diseases Program (RESP) ...
NEXT READ Charting the course to a post-pandemic world The RI-MUHC in numbers ...
NEXT READ Funding summary and worldwide network Salary awards PREVIOUS...
RI-MUHC ANNUAL REPORT 2021AWARDS AND RECOGNITIONThierry AlcindorSarcoma Track Leader, American Society of Clinical Oncology meetingMarc...
RI-MUHC ANNUAL REPORT 2021YOUR SUPPORTTOGETHER WE HAVE THE MEANS TO LEVERAGE DISCOVERIES THAT IMPROVE THE HEALTH OF PATIENTS ACROSS THEIR...
RI-MUHC ANNUAL REPORT 2021FUNDING SUMMARY AND WORLDWIDE NETWORKOngoing research collaborations with 68 countriesOUR RESEARCH NETWORKNorth...
RI-MUHC ANNUAL REPORT 2021EXECUTIVE MESSAGESMESSAGE FROM MIGUEL BURNIER JR.During this extraordinary year, the COVID-19 pandemic forced the...
RI-MUHC ANNUAL REPORT 2021BUSINESS DEVELOPMENT ACTIVITIESREPURPOSING AN EXISTING DRUG TO TREAT COVID-19Dr. Elena Netchiporouk embarked on a...
RI-MUHC ANNUAL REPORT 2021THE RI-MUHC IN NUMBERS: 2020-2021472 active members,including fundamental,clinical and evaluativeresearchers...
NEXT READ Salary awards Awards and recognition PREVIOUS READ ...
RI-MUHC ANNUAL REPORT 2021 FOCUS ON OUR TRAINEESWHAT IS OUR NEW GENERATION OF RESEARCHERS ACHIEVING TODAY?Over 1,200 research trainees play...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWINJURY REPAIR RECOVERY (IRR) PROGRAMRESEARCH HIGHLIGHTSPatients’ perspectives: “When will I...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCANCER RESEARCH PROGRAM (CRP)RESEARCH HIGHLIGHTSOvercoming the resistance of bladder tumours to...